Teleflex Reports Study Results of ARROWg+ard® Technology Effectiveness in Preventing Infections and Associated Costs in an Infection-Prone Insertion Site
The ARROW® CVC with ARROWg+ard® Technology outperformed the unprotected CVC in both infection reduction and total cost per patient. Within the study, the protected catheter achieved a zero infection rate per 1,000 catheter days.
Read the Press Release »
Teleflex announces Restated Indications for Use for EZ-IO® Vascular Access System.
Teleflex has announced FDA 510(k) clearance for restated Indications for Use of the EZ-IO® Vascular Access System. The EZ-IO® 25mm Needle Set is now indicated for patients 3 kg or over.
"The restated indication for the EZ-IO® 25mm Needle Set will help to avoid confusion and streamline care" states Mark L. Waltzman, MD, FAAP.
For more information and the new weight classifications for the EZ-IO® Vascular Access System, read the Press Release »
Your Partner in Innovation. We’re looking for good ideas to take medical device design further in innovation and patient care. More »